 Comparison plasma exchange plasma infusion treatment thrombotic thrombocytopenic purpura Canadian Apheresis Study Group BACKGROUND Thrombotic thrombocytopenic purpura uncommon disease high mortality rate current treatment cause syndrome optimal treatment unknown plasma exchange plasma infusion useful treatments clear superior report prospective trial plasma exchange plasma infusion treatment thrombotic thrombocytopenic purpura METHODS patients thrombotic thrombocytopenic purpura plasma exchange infusion fresh-frozen plasma first days entry trial total volume plasma patients plasma exchange times patients plasma infusion patients aspirin dipyridamole outcomes groups end first treatment cycle day months RESULTS end first treatment cycle patients plasma exchange rate response increase platelet count patients plasma infusion patients plasma exchange patients plasma infusion months outcome plasma-exchange group superior response patients whereas patients plasma-infusion group Eleven patients plasma-exchange group patients plasma-infusion group overall mortality percent CONCLUSIONS Plasma exchange effective plasma infusion treatment thrombotic thrombocytopenic purpura